Primary lung cancer presenting with gastrointestinal tract involvement: Clinicopathologic and immunohistochemical features in a series of 18 consecutive cases

Journal of Thoracic Oncology

Volumn 2, Issue 2, 2007, Pages 115-120

  Rossi, Giulio ^a   Marchioni, Alessandro ^b   Romagnani, Elena ^a   Bertolini, Federica ^a   Longo, Lucia ^c   Cavazza, Alberto ^d   Barbieri, Fausto ^c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Civic Hospital of Mirandola   (Italy)

^c Hospital Ramazzini   (Italy)

^d S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

Gastrointestinal tract; Immunohistochemistry; Lung cancer; Metastasis; TTF 1

Indexed keywords

CYTOKERATIN; CYTOKERATIN 20; CYTOKERATIN 7; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR CDX2;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL TRACT; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE INTESTINE; LUNG ADENOCARCINOMA; LUNG BIOPSY; LUNG CANCER; LUNG CARCINOMA; LUNG LOBECTOMY; LUNG RESECTION; MALE; MORPHOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SMALL INTESTINE; STOMACH; UNDIFFERENTIATED CARCINOMA; VISCERAL METASTASIS; GASTROINTESTINAL TUMOR; LUNG TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY;

AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 34247124145     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/S1556-0864(15)30037-X     Document Type: Article

References (37)

1. Menuck LS, Amberg JR. Metastatic disease involving the stomach. Am J Dig Dis 1975;20:903-913.
2. Edwards R, Royle G. Metastatic carcinoma causing haematemesis. Br Med J 1975;14:598
3. McNeill PM, Wagman LD, Neifeld JP. Small bowel metastases from primary carcinoma of the lung. Cancer 1987;59:1486-1489.
4. Antler AS, Ough Y, Pitchumoni CS, Davidian M, Thelmo W. Gastrointestinal metastases from malignant tumors of the lung. Cancer 1982;49:170-172.
5. Mosier DM, Bloch RS, Cunningham PL, Dorman SA. Small bowel metastases from primary lung carcinoma: a rarity waiting to be found? Am Surg 1992;58:677-682.
6. Stenbygaard LE, Sorensen JB. Small bowel metastases in non-small cell lung cancer. Lung Cancer 1999;26:95-101.
7. Berger A, Cellier C, Daniel C, et al. Small bowel metastases from primary carcinoma of the lung: clinical findings and outcome. Am J Gastroenterol 1999;94:1884-1887.
8. Hamilton SR, Aaltonen LA (Eds). Tumours of the Digestive System. Pathology and Genetics. World Health Organization Classification of Tumours. Lyon, France: IARC Press, 2000.
9. Galsky M, Darling M, Hecht J, Salgia R. Small bowel obstruction due to metastatic lung cancer. J Clin Oncol 2000;18:227-228.
10. Kim HS, Jang WI, Hong HS, et al. Metastatic involvement of the stomach secondary to lung carcinoma. J Korean Med Sci 1993;8:24-29.
11. Hsu CC, Chen JJ, Changchien CS. Endoscopic features of metastatic yumors in the upper gastrointestinal tract. Endoscopy 1996;28:249-253.
12. Lee KA, Lee SK, Seo DW, Kim MH. Duodenal metastasis from lung cancer presenting as obstructive jaundice. Gastrointest Endosc 2001;54:228.
13. Campoli de Oliveira PM, Ejima FH, Cardoso DM, et al. Metastatic cancer to the stomach. Gastric Cancer 2006;9:19-25.
14. Woods JM, Koretz MJ. Emergency abdominal surgery for complications of metastatic lung carcinoma. Arch Surg 1990;125:583-585.
15. Kadakia SC, Parker A, Canales L. Metastatic tumors to the upper gastrointestinal tract: endoscopic experience. Am J Gastroenterol 1992;87:1418-1423.
16. Akahoshi K, Chijiiwa Y, Hirota I, et al. Metastatic large-cell lung carcinoma presenting as gastrointestinal hemorrhage. Acta Gastroenterol Belg 1996;59:217-219.
17. Linares Santiago E, Romero Vazquez FJ, Gomez Parra M, et al. Lung adenocarcinoma diagnosed by the presence of duodenal and jejunal metastases [in Spanish]. Rev Esp Enfer Dig 2005;97:62-64.
18. Garwood RA, Sawyer MD, Ledesma EJ, et al. A case and review of bowel perforation secondary to metastatic lung cancer. Am Surg 2005;71:110-116.
19. Chatelain D, Bartoli E, Flamant M, et al. Role of TTF-1 immunohistochemistry for the diagnosis of duodenal metastasis of pulmonary adenocarcinoma [in French]. Gastroenterol Clin Biol 2005;29:208-209.
20. Tomas D, Ledinsky M, Belicza M, Kruslin B. Multiple metastases to the small bowel from large cell bronchial carcinomas. World J Gastroenterol 2005;11:1399-1402.
21. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (Eds). Tumours of the Lung, Pleura, Thymus and Heart. Pathology and Genetics. World Health Organization Classification of Tumours. Lyon, France: IARC Press, 2004.
22. Ginsberg SS, Buzaid AC, Stern H, Carter D. Giant cell carcinoma of the lung. Cancer 1992;70:606-610.
23. Irving JA, Young RH. Lung carcinoma metastatic to the ovary. A clinicopathologic study of 32 cases emphasizing their morphologic spectrum and problems in differential diagnosis. Am J Surg Pathol 2005;29:997-1006.
24. Reid-Nicholson M, Idrees M, Perino G, Hytiroglu P. Sarcomatoid carcinoma of the small intestine. A case report and review of the literature. Arch Pathol Lab Med 2004;128:918-921.
25. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology 2002;40:403-439.
26. Chen ZME, Wang HL. Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine. Am J Surg Pathol 2004;28:1352-1359.
27. Zhang PJ, Shah M, Spiegel GW, Brooks JJ. Cytokeratin 7 immunoreactivity in rectal adenocarcinomas. Appl Immunohistochem Mol Morphol 2003;11:306-310.
28. Lau SK, Luthringer DJ, Eisen RN. Thyroid transcription factor-1: a review. Appl Immunohistochem Mol Morphol 2002;10:97-102.
29. Stenhouse G, Fyfe N, King G, Chapman A, Kerr KM. Thyroid transcription factor 1 in pulmonary adenocarcinoma. J Clin Pathol 2004;57:383-387.
30. Rossi G, Cavazza A, Sturm N, et al. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Pathol 2003;27:311-324.
31. Kaufmann O, Dietel M. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology 2000;36:8-16.
32. Rossi G, Marchioni A, Milani M, et al. TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung. Am J Clin Pathol 2004;122:884-893.
33. Werling RW, Yaziji H, Bacchi CE, Gown AM. CDX-2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin. An immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol 2003;27:303-310.
34. Pfister DG, Johnson DH, Azzoli CG, et al. American Society of Clinical Oncology treatment of unresectable non-small cell cancer guideline: update 2003. J Clin Oncol 2004;22:330-353.
35. Martins R, Kelly K, Socinsky MA, Lynch TJ. Management of Metastatic Non-Small Cell Lung Cancer in 2006: Innovations And Unique Clinical Scenarios. Educational book from the 42nd Annual Meeting of the American Society of Clinical Oncology (ASCO), Atlanta, GA, June 2-6, 2006, pp. 418-423.
36. Nagashima A, Abe Y, Yamada S, Nagakawa M, Yoshimatsu T. Longterm survival after surgical resection of liver metastasis from lung cancer. Jpn J Thorac Cardiovasc Surg 2004;52:311-313.
37. Kim KS, Na KJ, Kim YH, et al. Surgically resected isolated hepatic metastasis from non-small cell lung cancer: a case report. J Thorac Oncol 2006;1:494-496.